181
Views
11
CrossRef citations to date
0
Altmetric
Original

Lead and cognitive function in adults: A questions and answers approach to a review of the evidence for cause, treatment, and prevention

&
Pages 671-692 | Received 01 Dec 2006, Accepted 15 Apr 2007, Published online: 11 Jul 2009

References

  • Ahmed NS, el-Gendy KS, el-Refaie AK, Marzouk SA, Bakry NS, el-Sebae AH, et al. Assessment of lead toxicity in traffic controllers of Alexandria, Egypt, road intersections. Arch Environ Health 1987; 42: 92–95
  • Araki S, Yokoyama K, Aono H, Murata K. Psychological performance in relation to central and peripheral nerve conduction in workers exposed to lead, zinc, and copper. Am J Ind Med 1986; 9: 535–542
  • Arnvig E, Grandjean P, Beckmann J. Neurotoxic effects of heavy lead exposure determined with psychological tests. Toxicol Lett 1980; 5: 399–404
  • ATSDR. Toxicological profile for lead. Update. Department of Health and Human Services, Public Health Service, Atlanta, GAUS 1999, 1999 Agency for Toxic Substances and Disease Registry
  • Baghurst PA, McMichael AJ, Tong S, Wigg NR, Vimpani GV, Robertson EF. Exposure to environmental lead and visual-motor integration at age 7 years: The Port Pirie Cohort Study. Epidemiology 1995; 6: 104–109
  • Baghurst PA, McMichael AJ, Wigg NR, Vimpani GV, Robertson EF, Roberts RJ, et al. Environmental exposure to lead and children's intelligence at the age of seven years. The Port Pirie Cohort Study. N Engl J Med 1992; 327: 1279–1284
  • Baker EL, Feldman RG, White RA, Harley JP, Niles C, Dinse GE, et al. Occupational lead neurotoxicity: A behavioural and electrophysiological evaluation. Study design and year one results. Br J Ind Med 1984; 41: 352–361
  • Baker EL, Feldman RG, White RF, Harley JP. The role of occupational lead exposure in the genesis of psychiatric and behavioral disturbances. Acta Psychiatr Scand Suppl 1983; 303: 38–48
  • Baker EL, White RF, Pothier LJ, Berkey CS, Dinse GE, Travers PH, et al. Occupational lead neurotoxicity: Improvement in behavioural effects after reduction of exposure. Br J Ind Med 1985; 42: 507–516
  • Balbus-Kornfeld JM, Stewart W, Bolla KI, Schwartz BS. Cumulative exposure to inorganic lead and neurobehavioural test performance in adults: An epidemiological review. Occup Environ Med 1995; 52: 2–12
  • Barth A, Schaffer AW, Osterode W, Winker R, Konnaris C, Valic E, et al. Reduced cognitive abilities in lead-exposed men. Int Arch Occup Environ Health 2002; 75: 394–398
  • Bartzokis G. Age-related myelin breakdown: A developmental model of cognitive decline and Alzheimer's disease. Neurobiol Aging 2004; 25: 5–18; , author reply 49–62
  • Basha MR, Wei W, Bakheet SA, Benitez N, Siddiqi HK, Ge YW, et al. The fetal basis of amyloidogenesis: Exposure to lead and latent overexpression of amyloid precursor protein and beta-amyloid in the aging brain. J Neurosci 2005; 25: 823–829
  • Bellinger D, Hu H, Titlebaum L, Needleman HL. Attentional correlates of dentin and bone lead levels in adolescents. Arch Environ Health 1994a; 49: 98–105
  • Bellinger D, Leviton A, Allred E, Rabinowitz M. Pre- and postnatal lead exposure and behavior problems in school-aged children. Environ Res 1994b; 66: 12–30
  • Bellinger D, Leviton A, Needleman HL, Waternaux C, Rabinowitz M. Low-level lead exposure and infant development in the first year. Neurobehav Toxicol Teratol 1986; 8: 151–161
  • Bergdahl IA, Grubb A, Schutz A, Desnick RJ, Wetmur JG, Sassa S, et al. Lead binding to delta-aminolevulinic acid dehydratase (ALAD) in human erythrocytes. Pharmacol Toxicol 1997; 81: 153–158
  • Bleecker ML, Ford DP, Lindgren KN, Hoese VM, Walsh KS, Vaughan CG. Differential effects of lead exposure on components of verbal memory. Occup Environ Med 2005; 62: 181–187
  • Bleecker ML, Lindgren KN, Ford DP. Differential contribution of current and cumulative indices of lead dose to neuropsychological performance by age. Neurology 1997; 48: 639–645
  • Bogden JD, Gertner SB, Christakos S, Kemp FW, Yang Z, Katz SR, et al. Dietary calcium modifies concentrations of lead and other metals and renal calbindin in rats. J Nutr 1992; 122: 1351–1360
  • Bogden JD, Gertner SB, Kemp FW, McLeod R, Bruening KS, Chung HR. Dietary lead and calcium: Effects on blood pressure and renal neoplasia in Wistar rats. J Nutr 1991; 121: 718–728
  • Bogden JD, Kemp FW, Han S, Murphy M, Fraiman M, Czerniach D, et al. Dietary calcium and lead interact to modify maternal blood pressure, erythropoiesis, and fetal and neonatal growth in rats during pregnancy and lactation. J Nutr 1995; 125: 990–1002
  • Bolla KI, Schwartz BS, Stewart W, Rignani J, Agnew J, Ford DP. Comparison of neurobehavioral function in workers exposed to a mixture of organic and inorganic lead and in workers exposed to solvents. Am J Ind Med 1995; 27: 231–246
  • Braak H, Del Tredici K. Poor and protracted myelination as a contributory factor to neurodegenerative disorders. Neurobiol Aging 2004; 25: 19–23
  • Bradbury MW, Deane R. Permeability of the blood-brain barrier to lead. Neurotoxicology 1993; 14: 131–136
  • Braga MF, Pereira EF, Mike A, Albuquerque EX. Pb2 + via protein kinase C inhibits nicotinic cholinergic modulation of synaptic transmission in the hippocampus. J Pharmacol Exp Ther 2004; 311: 700–710
  • Calne DB, Eisen A, McGeer E, Spencer P. Alzheimer's disease, Parkinson's disease, and motoneurone disease: A biotrophic interaction between ageing and environment?. Lancet 1986; 2: 1067–1070
  • Campara P, D'Andrea F, Micciolo R, Savonitto C, Tansella M, Zimmermann-Tansella C. Psychological performance of workers with blood-lead concentration below the current threshold limit value. Int Arch Occup Environ Health 1984; 53: 233–246
  • Casanova I. Clair C. Patterson (1922–1995), discoverer of the age of the Earth. Int Microbiol 1998; 1: 231–232
  • Inorganic lead exposure: Metabolism and intoxication, N Castellino, P Castellino, N Sannolo. Lewis Publishers, Boca Raton, FL 1995
  • Cavalleri A, Minoia C, Ceroni M, Poloni M. Lead in cerebrospinal fluid and its relationship to plasma lead in humans. J Appl Toxicol 1984; 4: 63–65
  • Chettle DR, Scott MC, Somervaille LJ. Lead in bone: Sampling and quantitation using K X-rays excited by 109Cd. Environ Health Perspect 1991; 91: 49–55
  • Chia SE, Chia HP, Ong CN, Jeyaratnam J. Cumulative blood lead levels and neurobehavioral test performance. Neurotoxicology 1997; 18: 793–803
  • Cholewa M, Hanson AL, Jones KW, McNally WP, Fand I. Regional distribution of lead in the brains of lead-intoxicated adult mice. Neurotoxicology 1986; 7: 9–18
  • Cory-Slechta DA. Mobilization of lead over the course of DMSA chelation therapy and long-term efficacy. J Pharmacol Exp Ther 1988; 246: 84–91
  • Cory-Slechta DA, Virgolini MB, Thiruchelvam M, Weston DD, Bauter MR. Maternal stress modulates the effects of developmental lead exposure. Environ Health Perspect 2004; 112: 717–730
  • Cory-Slechta DA, Weiss B, Cox C. Mobilization and redistribution of lead over the course of calcium disodium ethylenediamine tetraacetate chelation therapy. J Pharmacol Exp Ther 1987; 243: 804–813
  • Davey FD, Breen KC. The interaction between chronic low-level lead and the amyloid beta precursor protein. Amyloid 1998; 5: 90–98
  • Derogatis LR, Melisaratos N. The Brief Symptom Inventory: An introductory report. Psychol Med 1983; 13: 595–605
  • Dorsey CD, Lee BK, Bolla KI, Weaver VM, Lee SS, Lee GS, et al. Comparison of patella lead with blood lead and tibia lead and their associations with neurobehavioral test scores. J Occup Environ Med 2006; 48: 489–496
  • Ehle AL, McKee DC. Neuropsychological effect of lead in occupationally exposed workers: A critical review. Crit Rev Toxicol 1990; 20: 237–255
  • Espinosa AS, Canepa CD, Hermosilla PD, de Jong C, Horta E, Herrera C, . Study of neurobehavioral disturbances from lead exposure using neuropsychological indicators. Advances in neurobehavioral toxicology: Applications in environmental and occupational health, BL Johnson, et al. Lewis Publisher, Inc, Chelsea, MI 1990; 339–352
  • Ferguson C, Kern M, Audesirk G. Nanomolar concentrations of inorganic lead increase Ca2 + efflux and decrease intracellular free Ca2 + ion concentrations in cultured rat hippocampal neurons by a calmodulin-dependent mechanism. Neurotoxicology 2000; 21: 365–378
  • Finkelstein Y, Markowitz ME, Rosen JF. Low-level lead-induced neurotoxicity in children: An update on central nervous system effects. Brain Res Brain Res Rev 1998; 27: 168–176
  • Fishel ML, Vasko MR, Kelley MR. DNA repair in neurons: So if they don't divide what's to repair?. Mutat Res 2006
  • Flegal AR. Clair Patterson's influence on environmental research. Environ Res 1998; 78: 64–70
  • Fried LP, Borhani NO, Enright P, Furberg CD, Gardin JM, Kronmal RA, et al. The Cardiovascular Health Study: Design and rationale. Ann Epidemiol 1991; 1: 263–276
  • Frisch M, Schwartz BS. The pitfalls of hair analysis for toxicants in clinical practice: Three case reports:. Environ Health Perspect 2002; 110: 433–436
  • Fullmer CS. Dietary calcium levels and treatment interval determine the effects of lead ingestion on plasma 1,25-dihydroxyvitamin D concentration in chicks. J Nutr 1995; 125: 1328–1333
  • Gilbert ME, Kelly ME, Samsam TE, Goodman JH. Chronic developmental lead exposure reduces neurogenesis in adult rat hippocampus but does not impair spatial learning:. Toxicol Sci 2005; 86: 365–374
  • Glantz LA, Gilmore JH, Lieberman JA, Jarskog LF. Apoptotic mechanisms and the synaptic pathology of schizophrenia. Schizophr Res 2006; 81: 47–63
  • Glass TA, Rasmussen MR, Schwartz BS. Neighbourhoods and obesity in older adults: the Baltimore Memory Study. Am J Prev Med 2006; 31: 455–463
  • Goodman M, LaVerda N, Clarke C, Foster ED, Iannuzzi J, Mandel J. Neurobehavioural testing in workers occupationally exposed to lead: Systematic review and meta-analysis of publications. Occup Environ Med 2002; 59: 217–223
  • Gorell JM, Johnson CC, Rybicki BA, Peterson EL, Kortsha GX, Brown GG, et al. Occupational exposures to metals as risk factors for Parkinson's disease. Neurology 1997; 48: 650–658
  • Gorell JM, Johnson CC, Rybicki BA, Peterson EL, Kortsha GX, Brown GG, et al. Occupational exposure to manganese, copper, lead, iron, mercury and zinc and the risk of Parkinson's disease:. Neurotoxicology 1999; 20: 239–247
  • Gowers WR. A lecture on abiotrophy. Lancet 1902; I: 1003–1007
  • Grandjean P, Arnvig E, Beckmann J. Psychological dysfunctions in lead-exposed workers. Relation to biological parameters of exposure. Scand J Work Environ Health 1978; 4: 295–303
  • Guilarte TR. Pb2 + inhibits NMDA receptor function at high and low affinity sites: developmental and regional brain expression. Neurotoxicology 1997; 18: 43–51
  • Guilarte TR. Prenatal lead exposure and schizophrenia: A plausible neurobiologic connection. Environ Health Perspect 2004; 112: A724
  • Guilarte TR, Toscano CD, McGlothan JL, Weaver SA. Environmental enrichment reverses cognitive and molecular deficits induced by developmental lead exposure. Ann Neurol 2003; 53: 50–56
  • Gurland BJ, Wilder DE, Lantigua R, Stern Y, Chen J, Killeffer EH, et al. Rates of dementia in three ethnoracial groups. Int J Geriatr Psychiatry 1999; 14: 481–493
  • Haenninen H, Hernberg S, Mantere P, Vesanto R, Jalkanen M. Psychological performance of subjects with low exposure to lead. J. Occup Med 1978; 20: 683–689
  • Hanninen H, Aitio A, Kovala T, Luukkonen R, Matikainen E, Mannelin T, et al. Occupational exposure to lead and neuropsychological dysfunction. Occup Environ Med 1998; 55: 202–209
  • Hogstedt C, Hane M, Agrell A, Bodin L. Neuropsychological test results and symptoms among workers with well-defined long-term exposure to lead. Br J Ind Med 1983; 40: 99–105
  • Hursh JB, Suomela J. Absorption of 212Pb from the gastrointestinal tract of man. Acta Radiol Ther Phys Biol 1968; 7: 108–120
  • Jeyaratnam J, Boey KW, Ong CN, Chia CB, Phoon WO. Neuropsychological studies on lead workers in Singapore. Br J Ind Med 1986; 43: 626–629
  • Kamel F, Umbach DM, Munsat TL, Shefner JM, Hu H, Sandler DP. Lead exposure and amyotrophic lateral sclerosis. Epidemiology 2002; 13: 311–319
  • Kosnett MJ, Wedeen RP, Rothenberg SJ, Hipkins KL, Matera BL, Schwartz BS, et al. Recommendations for medical management of adult lead exposure. Environ Health Perspect 2007; 115: 463–471
  • Krantic S, Mechawar N, Reix S, Quirion R. Molecular basis of programmed cell death involved in neurodegeneration. Trends Neurosci 2005; 28: 670–676
  • Lanphear BP, Hornung R, Khoury J, Yolton K, Baghurst P, Bellinger DC, et al. Low-level environmental lead exposure and children's intellectual function: An international pooled analysis. Environ Health Perspect 2005; 113: 894–899
  • LeBlanc AC. The role of apoptotic pathways in Alzheimer's disease neurodegeneration and cell death. Curr Alzheimer Res 2005; 2: 389–402
  • Leggett RW. An age-specific kinetic model of lead metabolism in humans. Environ Health Perspect 1993; 101: 598–616
  • Lever SZ, Scheffel U. Regional distribution of 203PbCl2 in the mouse after intravenous injection. Neurotoxicology 1998; 19: 197–207
  • Lin C, Kim R, Tsaih SW, Sparrow D, Hu H. Determinants of bone and blood lead levels among minorities living in the Boston area. Environ Health Perspect 2004; 112: 1147–1151
  • Lindgren KN, Masten VL, Ford DP, Bleecker ML. Relation of cumulative exposure to inorganic lead and neuropsychological test performance. Occup Environ Med 1996; 53: 472–477
  • Lindgren KN, Masten VL, Tiburzi MJ, Ford DP, Bleecker ML. The factor structure of the Profile of Mood States (POMS) and its relationship to occupational lead exposure. J Occup Environ Med 1999; 41: 3–10
  • Links JM, Schwartz BS, Simon D, Bandeen-Roche K, Stewart WF. Characterization of toxicokinetics and toxicodynamics with linear systems theory: Application to lead-associated cognitive decline. Environ Health Perspect 2001; 109: 361–368
  • Lucchini R, Albini E, Cortesi I, Placidi D, Bergamaschi E, Traversa F, et al. Assessment of neurobehavioral performance as a function of current and cumulative occupational lead exposure. Neurotoxicology 2000; 21: 805–811
  • Lustberg M, Silbergeld E. Blood lead levels and mortality. Arch Intern Med 2002; 162: 2443–2449
  • Maizlish NA, Parra G, Feo O. Neurobehavioural evaluation of Venezuelan workers exposed to inorganic lead. Occup Environ Med 1995; 52: 408–414
  • Mantere P, Hanninen H, Hernberg C, Luukkonen R. A prospective follow-up study on psychological effects in workers exposed to low levels of lead. Scand J Work Environ Health 1984; 10: 43–50
  • Marchioro M, Swanson KL, Aracava Y, Albuquerque EX. Glycine and calcium-dependent effects of lead on N-methyl-D-aspartate receptor function in rat hippocampal neurons. J Pharmacol Exp Ther 1996; 279: 143–153
  • Markovac J, Goldstein GW. Lead activates protein kinase C in immature rat brain microvessels. Toxicol Appl Pharmacol 1988; 96: 14–23
  • Martin D, Glass TA, Bandeen-Roche K, Todd AC, Shi W, Schwartz BS. Association of blood lead and tibia lead with blood pressure and hypertension in a community sample of older adults. Am J Epidemiol 2006; 163: 467–478
  • McMichael AJ, Baghurst PA, Vimpani GV, Wigg NR, Robertson EF, Tong S. Tooth lead levels and IQ in school-age children: The Port Pirie Cohort Study. Am J Epidemiol 1994; 140: 489–499
  • McMichael AJ, Baghurst PA, Wigg NR, Vimpani GV, Robertson EF, Roberts RJ. Port Pirie Cohort Study: Environmental exposure to lead and children's abilities at the age of four years. N Engl J Med 1988; 319: 468–475
  • McNair DM, Lorr M, Droppelman LF. Manual for the profile of mood states. Educational and Industrial Testing Service, San Diego, CA 1971
  • Meyer-Baron M, Seeber A. A meta-analysis for neurobehavioural results due to occupational lead exposure with blood lead concentrations < 70 microg/100 ml. Arch Toxicol 2000; 73: 510–518
  • Mike A, Pereira EF, Albuquerque EX. Ca(2+)-sensitive inhibition by Pb(2+) of alpha7-containing nicotinic acetylcholine receptors in hippocampal neurons. Brain Res 2000; 873: 112–123
  • Milburn H, Mitran E, Crockford GW. An investigation of lead workers for subclinical effects of lead using three performance tests. Ann Occup Hyg 1976; 19: 239–249
  • Momcilovic B, Alkhatib HA, Duerre JA, Cooley M, Long WM, Harris TR, et al. Environmental lead-210 and bismuth-210 accrue selectively in the brain proteins in Alzheimer disease and brain lipids in Parkinson disease. Alzheimer Dis Assoc Disord 2001; 15: 106–115
  • Muntner P, Menke A, DeSalvo KB, Rabito FA, Batuman V. Continued decline in blood lead levels among adults in the United States: The National Health and Nutrition Examination Surveys. Arch Intern Med 2005; 165: 2155–2161
  • Needleman HL. Lead poisoning in children: Neurologic implications of widespread subclinical intoxication. Semin Psychiatry 1973; 5: 47–54
  • Needleman HL. Lead levels and children's psychologic performance. N Engl J Med 1979; 301: 163
  • Needleman HL. Effects of low levels of lead exposure. Science 1992; 256: 294–295
  • Needleman HL. Clair Patterson and Robert Kehoe: Two views of lead toxicity. Environ Res 1998; 78: 79–85
  • Needleman HL, McFarland C, Ness RB, Fienberg SE, Tobin MJ. Bone lead levels in adjudicated delinquents. A case control study. Neurotoxicol Teratol 2002; 24: 711–717
  • Ong CN, Lee WR. Distribution of lead-203 in human peripheral blood in vitro. Br J Ind Med 1980; 37: 78–84
  • Opler MG, Brown AS, Graziano J, Desai M, Zheng W, Schaefer C, et al. Prenatal lead exposure, delta-aminolevulinic acid, and schizophrenia. Environ Health Perspect 2004; 112: 548–552
  • Osterberg K, Borjesson J, Gerhardsson L, Schutz A, Skerfving S. A neurobehavioural study of long-term occupational inorganic lead exposure. Sci Total Environ 1997; 201: 39–51
  • Parkinson DK, Ryan C, Bromet EJ, Connell MM. A psychiatric epidemiologic study of occupational lead exposure. Am J Epidemiol 1986; 123: 261–269
  • Pasternak G, Becker CE, Lash A, Bowler R, Estrin WJ, Law D. Cross-sectional neurotoxicology study of lead-exposed cohort. J Toxicol Clin Toxicol 1989; 27: 37–51
  • Patterson CC. Contaminated and Natural Lead Environments of Man. Arch Environ Health 1965; 11: 344–360
  • Payton M, Riggs KM, Spiro A, III, Weiss ST, Hu H. Relations of bone and blood lead to cognitive function: The VA Normative Aging Study. Neurotoxicol Teratol 1998; 20: 19–27
  • Pfister E, Bockelmann I, Darius S, Wurthmann C. [Inclusion of psychopathologic methods for diagnosis of early neurotoxic effects from lead and organic solvent mixtures]. Fortschr Neurol Psychiatr 1999; 67: 435–440
  • Pirkle JL, Brody DJ, Gunter EW, Kramer RA, Paschal DC, Flegal KM, et al. The decline in blood lead levels in the United States. The National Health and Nutrition Examination Surveys (NHANES). JAMA 1994; 272: 284–291
  • Prince M. Is chronic low-level lead exposure in early life an etiologic factor in Alzheimer's disease?. Epidemiology 1998; 9: 618–621
  • Rabinowitz MB. Toxicokinetics of bone lead. Environ Health Perspect 1991; 91: 33–37
  • Rabinowitz MB, Wetherill GW, Kopple JD. Kinetic analysis of lead metabolism in healthy humans. J Clin Invest 1976; 58: 260–270
  • Radloff LS. The CES-D scale: A self report depression scale for research in the general population. Appl Psychol Measurement 1977; 1: 385–401
  • Raghavan SR, Gonick HC. Isolation of low-molecular-weight lead-binding protein from human erythrocytes. Proc Soc Exp Biol Med 1977; 155: 164–716
  • Ramesh GT, Manna SK, Aggarwal BB, Jadhav AL. Lead exposure activates nuclear factor kappa B, activator protein-1, c-Jun N-terminal kinase and caspases in the rat brain. Toxicol Lett 2001; 123: 195–207
  • Repko JD, Jones PD, Garcia LS, Corum CR. The effects of inorganic lead on behavioral and neurologic function. Department of Health, Education, and Welfare, Public Health Services, National Institute for Occupational Safety and Health, 103, Cincinnati, OH: US 1977
  • Rhodes D, Spiro A, III, Aro A, Hu H. Relationship of bone and blood lead levels to psychiatric symptoms: The normative aging study. J Occup Environ Med 2003; 45: 1144–1151
  • Roels H, Konings J, Green S, Bradley D, Chettle D, Lauwerys R. Time-integrated blood lead concentration is a valid surrogate for estimating the cumulative lead dose assessed by tibial lead measurement. Environ Res 1995; 69: 75–82
  • Ryan CM, Morrow L, Parkinson D, Bromet E. Low level lead exposure and neuropsychological functioning in blue collar males. Int J Neurosci 1987; 36: 29–39
  • Scahill RI, Frost C, Jenkins R, Whitwell JL, Rossor MN, Fox NC. A longitudinal study of brain volume changes in normal aging using serial registered magnetic resonance imaging. Arch Neurol 2003; 60: 989–994
  • Schwartz BS, Bolla KI, Stewart W, Ford DP, Agnew J, Frumkin H. Decrements in neurobehavioral performance associated with mixed exposure to organic and inorganic lead. Am J Epidemiol 1993; 137: 1006–1021
  • Schwartz BS, Glass TA, Bolla KI, Stewart WF, Glass G, Rasmussen M, et al. Disparities in cognitive functioning by race/ethnicity in the Baltimore Memory Study. Environ Health Perspect 2004; 112: 314–320
  • Schwartz BS, Lee BK, Bandeen-Roche K, Stewart W, Bolla K, Links J, et al. Occupational lead exposure and longitudinal decline in neurobehavioral test scores. Epidemiology 2005; 16: 106–113
  • Schwartz BS, Lee BK, Lee GS, Stewart WF, Lee SS, Hwang KY, et al. Associations of blood lead, dimercaptosuccinic acid-chelatable lead, and tibia lead with neurobehavioral test scores in South Korean lead workers. Am J Epidemiol 2001; 153: 453–464
  • Schwartz BS, Stewart W, Hu H. Neurobehavioural testing in workers occupationally exposed to lead. Occup Environ Med 2002; 59: 648–649
  • Schwartz BS, Stewart WF, Bolla KI, Simon PD, Bandeen-Roche K, Gordon PB, et al. Past adult lead exposure is associated with longitudinal decline in cognitive function. Neurology 2000; 55: 1144–1150
  • Seeber A, Meyer-Baron M. Neurobehavioural testing in workers occupationally exposed to lead. Occup Environ Med 2003; 60: 145, author reply 145–146
  • Shih RA, Glass TA, Bandeen-Roche K, Carlson MC, Bolla KI, Todd AC, et al. Environmental lead exposure and cognitive function in community-dwelling older adults. Neurology 2006; 67: 1556–1562
  • Shih RA, Hu H, Weisskopf MG, Schwartz BS. Cumulative lead dose and cognitive function in adults: A review of studies that measured both blood lead and bone lead. Environ Health Perspect 2007; 115: 483–492
  • Sola C, Barron S, Tusell JM, Serratosa J. The Ca2+/calmodulin system in neuronal hyperexcitability. Int J Biochem Cell Biol 2001; 33: 439–455
  • Spivey GH, Brown CP, Baloh RW, Campion DS, Valentine JL, Massey FJ, Jr., et al. Subclinical effects of chronic increased lead absorption - A prospective study. I. Study design and analysis of symptoms. J Occup Med 1979; 21: 423–429
  • Stewart WF, Schwartz BS, Davatzikos C, Shen D, Liu D, Wu X, et al. Past adult lead exposure is linked to neurodegeneration measured by brain MRI. Neurology 2006; 66: 1476–1484
  • Stewart WF, Schwartz BS, Simon D, Bolla KI, Todd AC, Links J. Neurobehavioral function and tibial and chelatable lead levels in 543 former organolead workers. Neurology 1999; 52: 1610–1617
  • Stewart WF, Schwartz BS, Simon D, Kelsey K, Todd AC. ApoE genotype, past adult lead exposure, and neurobehavioral function. Environ Health Perspect 2002; 110: 501–505
  • Stokes L, Letz R, Gerr F, Kolczak M, McNeill FE, Chettle DR, et al. Neurotoxicity in young adults 20 years after childhood exposure to lead: The Bunker Hill experience. Occup Environ Med 1998; 55: 507–516
  • Stollery BT, Banks HA, Broadbent DE, Lee WR. Cognitive functioning in lead workers. Br J Ind Med 1989; 46: 698–707
  • Stollery BT, Broadbent DE, Banks HA, Lee WR. Short term prospective study of cognitive functioning in lead workers. Br J Ind Med 1991; 48: 739–749
  • Suszkiw JB. Presynaptic disruption of transmitter release by lead. Neurotoxicology 2004; 25: 599–604
  • Tang MX, Cross P, Andrews H, Jacobs DM, Small S, Bell K, et al. Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians in northern Manhattan. Neurology 2001; 56: 49–56
  • Todd AC, Chettle DR. In vivo X-ray fluorescence of lead in bone: Review and current issues. Environ Health Perspect 1994; 102: 172–177
  • Todd AC, Ehrlich RI, Selby P, Jordaan E. Repeatability of tibia lead measurement by X-Ray fluorescence in a battery-making workforce. Environ Res 2000; 84: 282–289
  • Todd AC, Landrigan PJ. X-ray fluorescence analysis of lead in bone. Environ Health Perspect 1993; 101: 494–495
  • Todd AC, McNeill FE, Fowler BA. In vivo X-ray fluorescence of lead in bone. Environ Res 1992; 59: 326–335
  • Todd AC, Moshier EL, Carroll S, Casteel SW. Validation of X-ray fluorescence-measured swine femur lead against atomic absorption spectrometry. Environ Health Perspect 2001; 109: 1115–1119
  • Tsaih SW, Korrick S, Schwartz J, Lee ML, Amarasiriwardena C, Aro A, et al. Influence of bone resorption on the mobilization of lead from bone among middle-aged and elderly men: The Normative Aging Study. Environ Health Perspect 2001; 109: 995–999
  • Valciukas JA, Lilis R, Fischbein A, Selikoff IJ, Eisinger J, Blumberg WE. Central nervous system dysfunction due to lead exposure. Science 1978; 201: 465–467
  • Valciukas JA, Lilis R, Singer R, Fischbein A, Anderson HA, Glickman L. Lead exposure and behavioral changes: Comparisons of four occupational groups with different levels of lead absorption. Am J Ind Med 1980; 1: 421–426
  • Virgolini MB, Bauter MR, Weston DD, Cory-Slechta DA. Permanent alterations in stress responsivity in female offspring subjected to combined maternal lead exposure and/or stress. Neurotoxicology 2006; 27: 11–21
  • Virgolini MB, Chen K, Weston DD, Bauter MR, Cory-Slechta DA. Interactions of chronic lead exposure and intermittent stress: consequences for brain catecholamine systems and associated behaviors and HPA axis function. Toxicol Sci 2005; 87: 469–482
  • Virgolini MB, Volosin M, Fulginiti AS, Cancela LM. Amphetamine and stress responses in developmentally lead-exposed rats. Neurotoxicol Teratol 2004; 26: 291–303
  • Warren C. Brush with death: A social history of lead poisoning. Johns Hopkins University Press, Baltimore 2000
  • Weaver VM, Lee BK, Ahn KD, Lee GS, Todd AC, Stewart WF, et al. Associations of lead biomarkers with renal function in Korean lead workers. Occup Environ Med 2003; 60: 551–562
  • Weiss B. Vulnerability to pesticide neurotoxicity is a lifetime issue. Neurotoxicology 2000; 21: 67–73
  • Weiss B, Bellinger DC. Social ecology of children's vulnerability to environmental pollutants. Environ Health Perspect 2006; 114: 1479–1485
  • Weisskopf MG, Proctor SP, Wright RO, Schwartz J, Spiro A, III, Sparrow D, et al. Cumulative lead exposure and cognitive performance among elderly men. Epidemiology 2007; 18: 59–66
  • Weisskopf MG, Wright RO, Schwartz J, Spiro A, III, Sparrow D, Aro A, et al. Cumulative lead exposure and prospective change in cognition among elderly men: The VA Normative Aging Study. Am J Epidemiol 2004; 160: 1184–1193
  • Widzowski DV, Cory-Slechta DA. Homogeneity of regional brain lead concentrations. Neurotoxicology 1994; 15: 295–307
  • Williamson AM, Teo RK. Neurobehavioural effects of occupational exposure to lead. Br J Ind Med 1986; 43: 374–380
  • Wilson RS, Beckett LA, Barnes LL, Schneider JA, Bach J, Evans DA, et al. Individual differences in rates of change in cognitive abilities of older persons. Psychol Aging 2002; 17: 179–193
  • Winker R, Barth A, Ponocny-Seliger E, Pilger A, Osterode W, Rudiger HW. No cognitive deficits in men formerly exposed to lead. Wien Klin Wochenschr 2005; 117: 755–760
  • Winker R, Ponocny-Seliger E, Rudiger HW, Barth A. Lead exposure levels and duration of exposure absence predict neurobehavioral performance. Int Arch Occup Environ Health 2006; 79: 123–127
  • Wright RO, Tsaih SW, Schwartz J, Spiro A, III, McDonald K, Weiss ST, et al. Lead exposure biomarkers and mini-mental status exam scores in older men. Epidemiology 2003; 14: 713–718
  • Xie CW. Calcium-regulated signaling pathways: role in amyloid beta-induced synaptic dysfunction. Neuromolecular Med 2004; 6: 53–64
  • Yokoyama K, Araki S, Aono H. Reversibility of psychological performance in subclinical lead absorption. Neurotoxicology 1988; 9: 405–410
  • Zheng W. Neurotoxicology of the brain barrier system: New implications. J Toxicol Clin Toxicol 2001; 39: 711–719

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.